Since tumor necrosis factor (TNF)-a, interferon (IFN)-% and transforming growth factor (TGF)-[3 have all been shown to be specific inhibitors of early human hematopoiesis, we wanted to investigate the interactions of these three cytokines on very primitive human adult bone marrow CD34 § +CD38-hematopoietic progenitor cells, using a pre-colony-forming cell (pre-CFC) assay, which detects the effects of these cytokines on the initial phases of the differentiation of these primitive progenitors, which are unresponsive to interleukin (IL) 3 alone. Surprisingly, TNF-cx was a very potent stimulator of the proliferation of CD34 + +CD38-cells and was the most potent synergistic factor for the IL-3-induced proliferation of these cells of all cytokines tested (IL-1, IL-6, granulocyte colony-stimulating factor, kit ligand). TNF-o~ was the only cytokine that, as a single added factor, induced substantial proliferation in CD34 + +CD38-cells in the presence of IL-3, except for kit ligand, which induced very limited proliferation. TNF-c~, moreover, induced a high degree of resistance to the inhibitory effects of TGF-13 in a dose-dependent way. The inhibitory effects oflFN-% however, were not affected by the presence of TNF-ot. We hypothesize that in situations of hematopoietic stress, TNF-oL may abrogate the inhibitory effect of ambient TGF-[3 in the bone marrow microenvironment to allow primitive stem cells to proliferate and differentiate in response to an increased demand for mature blood cells.
T he proliferation and differentiation of primitive hematopoietic progenitor cells are regulated by direct interaction of these cells with bone marrow stroma and by the stimulatory and inhibitory effects of cytokines present in the microenvironment of the bone'fnarrow (1) .
Among cytokines inhibiting hematopoiesis, the action of TGF-[3 on progenitor cells has been characterized the best (2) (3) (4) (5) . The sensitivity of progenitor cells to the inhibitory effects of TGF-[3 is inversely correlated with their maturation stage: the proliferation and differentiation of a very primitive progenitor are profoundly inhibited by TGF- [3 (2-4) , whereas more mature progenitors are even stimulated in some circumstances (5) . We recently identified IFN-~/as a selective inhibitor of primitive human CD34 ++ CD38-progenitor cells (6) . TNF-o~ is a pleiotropic cytokine that is predominantly produced by macrophages (7) and has been shown by many investigators to be a bifunctional regulator of the proliferation and differentiation of more mature hematopoietic progenitor cells, depending on the cytokines present in the culture medium and on the degree of progenitor cell enrichment (8) (9) (10) . A number of reports from the same group have recently demonstrated that TNF-ot is another direct and selective inhibitor of very primitive stem cells in the human (11) (12) (13) and routine (14) systems. Others, however, have demonstrated stimulatory effects of TNF-cx on more primitive progenitors (10, 15) .
The aim of this work is to characterize the interactions of the three aforementioned hematopoietic inhibitors on purified human CD34++CD38 -cells, which have been shown to contain the most primitive identifiable human progenitors (6, 16) . We used a two-stage pre--colony-forming cell (pre-CFC) assay, since this allows the characterization of the effects of these cytokines on the initial phases of the proliferation of CD34++CD38 -cells (6, 17) . Surprisingly, TNF-o~ turned out to be a very powerful stimulator of the prohferation of CD34 § -cells and to induce resistance to the inhibitory effects of TGF-~3 but not IFN-~/.
Materials and Methods
Bone .Marrow Cells. Cell Sorting and Pre-CFU Assay. Labeling of low density bone marrow cells for CD34 and CD38 and isolation of CD34 § -cells by flow c-ytometric cell sorting were performed as described previously (6) . Primary liquid cultures of CD34+ § cells were performed in 96-well flat-bottom plates in duplicate at 100 cells/well in IMDM, 10% FCS, and combinations of the following recombinant human cytokines: 100 ng/ml IL-1, 200 U/ml IL-6, 30 U/ml IL-3, 100 ng/ml kit ligand (KL), and varying concentrations ofTNF-ix, TGF-13, and IFN-~. After 14 d of primary culture, the number of cells in each well was counted using an inverted microscope at a magnification of 250, after which the cells were harvested, washed three times in IMDM with 10% FCS, and plated in secondary methylcellulose cultures (0.9%) supplemented with 20% FCS, 1% BSA, 10 -5 M 2-ME, 30 U/ml IL-3, 100 ng/ml G-CSF, 100 ng/ml GM-CSF, and 2 U/ml epo, which were optimal concentrations for colony formation in preliminary experiments. These cultures were microscopically scored for colony formation after 14 d of culture at 37~ in 7.5% O 2 and 5% CO2 in a fully humidified incubator. To ascertain that the effects of TNFr(x in these experiments were direct, some experiments were performed at a single-cell level. CD34 + +CD38-cells were sorted at 1 cell/well in 96-well V-bottomed plates (two plates per cytokine combination). In test sorts using fluorescent microbeads, on average <2% of the wells contained no beads, and no wells were detected that contained more than one bead. Each well contained 100 Ixl of culture medium consisting of IMDM, 10% FCS, IL-3, and KL (concentrations as in the primary cultures described above) and either no TNF-(x or TNF-c( at 1 ng/ml. After 14 d of culture (37~ 5% 0 2, 5% CO 2 in a fully humidified incubator), the number of wells where growth had occurred was scored using an inverted microscope.
Statistics. In all experiments, Student's t test for paired samples was used.
Results

TNF-ee Stimulates the Proliferation and Differentiation of CD34++CD38 -Cells.
We have previously shown that CD34++CD38 -cells require at least the presence of IL-3, KL, and either G-CSF, IL-1, or IL-6 to proliferate and generate secondary CFC, Optimal proliferation is obtained in the presence of IL-3, KL, and two of the other aforementioned synergistic factors (6) . Since TNF-e~ has been reported to inhibit the proliferation of very primitive progenitor cells (11) (12) (13) (14) , we first investigated whether TNF-ot would inhibit the proliferation and differentiation of optimally stimulated CD34++CD38 -cells in a two-stage pre-CFC assay. As shown in Fig. 1 (horizontal line). Significant differences compared with control cultures are indicated with an asterisk, n = 13 except for TNF-c( 1 ng/ml, where n = 20, for TNF-0t 5 ng/ml, where n = 24, and for TNF-ix 25 ng/ml, where n = 7 (A); n = 7 except for TNF-(x 1 ng/ml, where n = 12, and for TNF-(x 5 ng/ml, where n = 16 (B).
crease in the number of cells obtained after 14 d of liquid culture. The stimulatory action of TNF-c~ was maximal between 0.5 and 2.5 ng/rnl and decreased at higher concentrations. Maximal cell expansion in the liquid cultures was on average increased 18-fold (P = 0.0001). This huge increase in cell number was paralleled by a somewhat less substantial increase in CFC output (Fig. 1 B) . The maximal increase in the number o f secondary CFC was on average 13-fold at 1 ng/ml o f TNF-e~ (P = 0.0001). Secondary colonies consisted mostly ofmacrophage and mixed granulocyte--macrophage colonies, with a minority o f pure granulocytic, erythroid, and mixed myeloid-erythroid colonies. N o preferential production o f any kind of CFC was noted after culture in the presence of TNF--a (not shown). At higher concentrations of T N F -a , no significant difference in CFC output was found compared with cultures without TNF-o~, although cell expansion after 14 d o f primary culture was significantly higher (fourfold at 5 ng/ml, P <0.05). To test whether this was caused by a more rapid differentiation of primitive progenitor cells in the presence of TNF-ci, secondary semisolid cultures were plated after 7 Table 1 , this effect was a direct one, since it could be reproduced in single-cell cultures o f CD34++CD38 -cells. In the presence o f neutralizing anti-TNF-r antibodies, no effect was seen (not shown). In the absence oflL-3, no proliferation is seen in cultures supported by TNF-e~ alone or by combinations of TNF-o~ with IL-1, IL-6, KL, and G-CSF (not shown). TNF-oL is thus a potent direct synergistic factor for very primitive progenitor cells that are unresponsive to IL-3 alone. IFN-'y was recently identified by our group as a potent direct inhibitor ofCD34++CD38 -cells (8) . As with TGF-13, the inhibitory effect of IFN-~/is specific for more primitive progenitor cells. In contrast to TGF-I3, however, an optimal concentration of IFN-'y (1,000 U/ml) induces the same relative inhibition o f the proliferation and differentiation of CD34++CD38 -cells in the presence compared with the absence o f TNF-c~, respectively (Fig. 3) . Significant differences compared with control cultures are indicated with an asterisk, n =-7, except for TGF-[3 5 ng/ml and TNF-e~ 0 ng/ml, where n = 27, TGF-13 5 ng/ml and TNF-c~ 1 ng/ml, where n = 20, and TGF-13 5 ng/ml and TNF-o~ 5 ng/ml, where n = 24 (A); n = 7, except for TGF-]3 5 ng/ml and TNF-cr 0 ng/ml, where n = 27, TGF-[3 5 ng/ ml and TNF-~ 1 ng/ml, where n = 20, and TGF-13 5 ng/ml and TNF-~ 5 ng/ml, where n = 24 (B).
TNF-ee Reverses the Inhibitory Effects of TGF-~ but Not IFN-T. TGF-[3 is well known as a potent inhibitor o f hematopoietic progenitor cells (2-4). Maximum inhibition is obtained at
tic progenitor cells, as defined by a high expression of CD34 and the absence of CD38 expression. As we and others have previously shown (6, 16) , these cells represent 1-5% of bone marrow CD34 + cells, need multiple growth factors, including at least IL-3 and KL, for proliferation, and do not form colonies in classic semisolid assays, but give rise to secondary C F C after liquid culture in the presence of appropriate combinations of growth factors. The absence of growth in the presence of IL-3 and the very low level of growth in the presence of IL-3 plus KL indicates that they are indeed very primitive cells (19) . TNF-or is the most potent synergistic factor for the IL-3-induced proliferation of these cells of the cytokines tested (KL, IL-1, IL-6, and G-CSF) and is the only cytokine, next to KL, that as a single added agent can induce proliferation in C D 3 4 + + C D 3 8 -cells cultured in the presence of IL-3. Moreover, the combination of IL-3 plus TNF-cx is much more potent than the combination of IL-3 Stimulatory effects of TNF-cx on very early hematopoietic progenitors have been reported before, but these reports dealt with populations that were still responsive to IL-3 alone (10, 15) . O n the other hand, although Rusten et al. (11) showed stimulatory effects of TNF-oL on I L -3 -and GM-CSF-responsive human progenitors, the same authors demonstrated an inhibitory effect of TNF-ot mediated by the p75 T N F receptor on very primitive high proliferative potenital (HPP) C F C in the murine (14) and human (11) system. Functionally, the cells used in the latter reports were similar to the cells described in this report, in that they have an HPP and are dependent on the presence of multiple growth factors for their proliferation. There is agreement, however, on the heterogenicity of the response of hematopoietic progenitor ceils to TNF-oL, depending on their differentiation stage, phenotype, and on the cytokines present in the culture medium. The fact that in our experiments only the effect on the initial phases of the proliferation of CD34++CD38 -cells were assessed might have played a role. This hypothesis is substantiated by existing evidence that TNF-cx recruits a more primitive subset of progenitors (15) while inducing a differentiation block downstream (10, 20) . Since the relative increase in the number of secondary C F C induced by TNF-& compared with cultures without TNF-ot is larger after 7 d of liquid culture than after 14 d of liquid culture, it follows that TNF-ot induces more rapid differentiation together with a stimulation of the proliferation of very primitive progenitors.
In this report, it is also shown for the first time that even very low concentrations (0.1 ng/ml) of TNF-er alleviate the profound inhibitory effect o f TGF-[3 on the proliferation o f very primitive human progenitor cells. At these low concentrations of TNF-~x, a profound inhibitory effect o f T G F -~ is still seen when compared with cultures without TGF-~, but, remarkably, at higher concentrations o f TNF-ot, a high degree o f resistance against the effects of TGF-I3 is induced. Other cytokines, such as IL-1, IL-6, G-CSF, and basic fibroblast growth factor (21) (22) (23) , have been shown to partially abrogat e the inhibitory effects o f TGFq3. In our experiments, however, T G F -~ was still profoundly inhibitory, despite the presence of many o f these factors. O n the other hand, the inhibitory effects o f IFN-~/ (6) were unaffected by the presence o f TNF-ci.
Stern cells are known to be inhibited and "protected" from the stimulatory effects of ambient hematopoietic stimulators by TGF-[3, produced autocrinely or paracrinely by stem cells and the surrounding bone marrow stroma (24, 25) . It is our hypothesis that in situations of increased demand for mature blood cells, TNF-ci, a typical inflammatory cytokine, induces resistance to the inhibitory effects o f TGF-13 so that these cells become responsive to the proliferative effects o f other cytokines. Exhaustion of the stem cells could be prevented by the fact that the selective inhibitory effect o f another inflammatory cytokine, IFN-2t, is not opposed by TNF-0e.
In conclusion, TNF-oe is a very potent synergistic stimulator of very primitive human hematopoietic progenitor cells and induces resistance in these cells to the effect o f TGF-13 but not IFN-~. 
